Speakers - Sachs Associates

More documents

Recommendations

Info

CONTACTS Dr Christof Böhler Chief Business Officer DDr Sven Rohmann Chief Business Officer ADDRESS Industriering 21 9494 Ruggell Liechtenstein TELEPHONE +423 377 78 00 FAX +423 377 78 99 EMAIL info@pantec-biosolutions.com YEAR FOUNDED 2005 Pantec Biosolutions AG www.pantec-biosolutions.com FINANCIAL SUMMARY Pantec is funded by private investors and one VC company. The company is seeking new investors alongside existing shareholders in a new financing round. COMPANY PROFILE Pantec Biosolutions is the leading company for stable and controlled dermal delivery of large weight biopharmaceuticals. Our goal is to replace injection based medication of biologicals in selected disease areas with the help of a breakthrough dermal delivery method. The proprietary combination of P.L.E.A.S.E.® (Precise Laser Epidermal System) microporation technology with intradermal drug delivery allows easy to use, safe, rapid and painless application of infertility hormones and other large molecular weight biopharmaceuticals. This platform significantly improves precise drug uptake in addition to reducing treatment duration and avoiding the need for injections. This technology has significant potential to unlock a high unmet need of treatments requiring large molecular weight biopharmaceuticals. The company’s focus is in combining laser of laser microporation with drug delivery in the dermatology and immunology space. In addition P.L.E.A.S.E.® can also be used “stand alone” as a new category fractional ablative laser device to break new ground in aesthetic dermatology. MANAGEMENT Dr Boehler Christof, CEO Mr Bragagna Thomas, CTO Dr Dr med. Rohmann Sven, CBO Dr. Clemens Norbert, Clinical Director as permanent consultant Dr Kalia Yogeshvar N, Chief Scientific Advisor t back :: next u WELCOME PHARMA LICENSING GROUPS SPEAKERS PRESENTING COMPANIES SUPPORTING ORGANISATIONS ORGANISERS
CONTACT Dr Erik Buntinx Chief Executive Officer ADDRESS Alkerstraat 30A B3570 Alken Belgium TELEPHONE +32 11 480 750 FAX +32 11 484 923 EMAIL Erik.buntinx @pharmaneuroboost.com YEAR FOUNDED 2006 PharmaNeuroBoost www.pharmaneuroboost.com COMPANY PROFILE Pharmaneuroboost is a privately held R&D company dedicated to develop CNS drugs with a significant added value compared to standard of care products available based on a solid IP protected platform. Current developments involve PNB01, a fixed combination product of citalopram and low dose pipamperone in Major Depression (phase III) and PNB02, a fixed combination product of risperidone and low dose pipamperone in Schizophrenia (phase II). MANAGEMENT Dr Erik Buntinx, Chief Executive Officer Dr Remi Van den Broeck, Chief Development Officer Dr Ludo Haazen, Chief Medical Officer Prof Didier de Chaffoy de Courcelles, Chief Science Officer t back :: next u WELCOME PHARMA LICENSING GROUPS SPEAKERS PRESENTING COMPANIES SUPPORTING ORGANISATIONS ORGANISERS
Page 1 and 2:
B I O T E C H I N E U R O P E I N V
Page 3 and 4:
Events Diary For regular updates, s
Page 5 and 6:
Speakers Alexey Eliseev, Managing D
Page 7 and 8:
Speakers Blake M. Paterson, Co-Foun
Page 9 and 10:
Speakers David Slack, Head of Corpo
Page 11 and 12:
Speakers Frank Grams, VP, Head Alli
Page 13 and 14:
Speakers Iain Buchanan, CEO, NOXXON
Page 15 and 16:
Speakers Juhani Lahdenperä, CEO, H
Page 17 and 18:
Speakers Marcel Zwaal, CBO, DCPrime
Page 19 and 20:
Speakers Paul Higham, Managing Dire
Page 21 and 22:
Speakers Richard Goodfellow, CEO, S
Page 23 and 24:
Speakers Søren Moller, Managing In
Page 25 and 26:
CONTACT Robert F Burns, PhD Chief E
Page 27 and 28:
CONTACTS Rostislav Raykov Chief Exe
Page 29 and 30: CONTACTS Vincent Charlon PhD, CEO Z
Page 31 and 32: CONTACTS Dr Bassam Damaj Chairman,
Page 33 and 34: CONTACT Carina Schmidt Chief Execut
Page 35 and 36: CONTACT Mr Richard Godfrey Chief Ex
Page 37 and 38: CONTACTS Tom Kronbach, PhD Chief Ex
Page 39 and 40: CONTACTS Andreas Caduff, PhD Chief
Page 41 and 42: CONTACTS Dr Blake Paterson Co-Found
Page 43 and 44: CONTACT Wolfgang Kintzel Chief Exec
Page 45 and 46: CONTACT Mike Romanos PhD Chief Exec
Page 47 and 48: CONTACT Harry Welten, MBA Chief Fin
Page 49 and 50: CONTACT Barbara Stiefel Office Mana
Page 51 and 52: CONTACTS Ana Martinez Assistant Jua
Page 53 and 54: CONTACTS Dr Rudi D Neirinckx Chief
Page 55 and 56: CONTACT Martin Bonde, PhD, BComm Ch
Page 57 and 58: CONTACT Benedikt Timmerman Chief Ex
Page 59 and 60: CONTACT Malcolm Weir Chief Executiv
Page 61 and 62: CONTACTS Mr Paul Higham Chief Execu
Page 63 and 64: CONTACTS Kevin FitzGerald Chief Ope
Page 65 and 66: CONTACT Roel Q. J Schaapveld, PhD,
Page 67 and 68: CONTACT Maaike Vogelezang Managemen
Page 69 and 70: CONTACT Tom Johnston Chief Executiv
Page 71 and 72: CONTACTS Aaron Powers President Dav
Page 73 and 74: CONTACTS General and Media Contact
Page 75 and 76: CONTACTS Martin Welschof Chief Exec
Page 77 and 78: CONTACTS Carlos Buesa Chief Executi
Page 79: CONTACTS Nick McCooke Chief Executi
Page 83 and 84: CONTACT Michael Altorfer, Ph.D. Hea
Page 85 and 86: CONTACT Matthew B. Lehman Chief Ope
Page 87 and 88: ADDRESS Otto-Hahn-Strasse 15 D- 442
Page 89 and 90: CONTACT Dr Roman Schenk Chief Execu
Page 91 and 92: CONTACTS Dr Hans Fliri Chairman Sim
Page 93 and 94: CONTACTS Dr Raúl Insa Chief Execut
Page 95 and 96: CONTACT Dr Johanna Holldack, MD Chi
Page 97 and 98: CONTACT Eduardo Bravo (speaker) Man
Page 99 and 100: CONTACTS Piers Morgan Chief Financi
Page 101 and 102: CONTACT Jakob Knudsen Chief Executi
Page 103 and 104: CONTACTS Dr Sonja Reingruber Chief
Page 105 and 106: Supporting Organisations Citigate D
Page 107 and 108: Supporting Organisations Life Scien
Page 109 and 110: Supporting Organisations Swiss Biot
Page 111 and 112: Supporting Organisations Torreya Pa
Page 113: B I O T E C H I N E U R O P E I N V
show all

Speakers - Sachs Associates

Create successful ePaper yourself

Delete template?

Save as template?